Centene Corp (NYSE:CNC) stock is 3.9% higher to trade at $27.75 this morning, even after the managed healthcare company reported an adjusted second-quarter loss of 16 cents per share, steeper than the 11 cents per share projected.
Centene (CNC) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of $0.68. This compares to earnings of $2.42 per share a year ago.
Health insurer Centene reported a $253 million loss in its second quarter as the provider of government-subsidized benefits struggles to manage costs of its health plan members.
Medical - Healthcare Plans Industry | Healthcare Sector | Sarah M. London CEO | LSE Exchange | GB0002183191 ISIN |
US Country | 60,400 Employees | - Last Dividend | 7 Feb 2019 Last Split | 13 Dec 2001 IPO Date |
Centene Corporation stands as a prominent healthcare enterprise catering to the essential healthcare needs of under-insured and uninsured families, commercial organizations, and military families within the United States. Distinguished by its commitment to providing comprehensive health programs and services, the company navigates through the complexity of healthcare needs across diverse populations. Established in 1984 and headquartered in Saint Louis, Missouri, Centene has carved a niche for itself in the healthcare sector by offering a wide array of services across its multiple operational segments including Medicaid, Medicare, Commercial, and Other segments. The company's focus on accessibility and quality care underlines its mission to deliver healthcare solutions that foster well-being and improve health outcomes for all its members.
Centene's product and service portfolio spans across several key areas of healthcare, addressing the needs of a vast demographic through its diversified offerings: